Optim.AI | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,290 results for “Optim.AI”

Trials

View all 1251 →

OPTImal Management of Antithrombotic Agents: OPTIMA-5

80 participants · First posted Oct 7, 2019

OPTImal Management of Antithrombotic Agents: OPTIMA-2 Trial

1,724 participants · First posted Oct 7, 2013

Optima Coronary Artery Disease (CAD) (Optimal Mechanical Evaluation)

50 participants · First posted May 11, 2009

Drugs

Benzalkonium chloride/octoxynol vaginal gel (Optima)

Organizations

Optimal Acuity Corporation.

OPTIMAL RX PTY LIMITED

Australia

News

View all 36 →

KYAN Technologies' Optim.AI Platform Demonstrates 85% Clinical Concordance Across Multiple Cancer Types

KYAN Technologies' Ex Vivo Platform Demonstrates Clinical Utility in Relapsed/Refractory Non-Hodgkin Lymphoma

Meta-Analysis Reveals Optimal Antibiotic Treatments for Acute Pyelonephritis

Page 1 of 129